Literature DB >> 34563677

Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.

Elodie Leroux1, Romain Perbet1, Raphaëlle Caillierez1, Kevin Richetin2, Sarah Lieger1, Jeanne Espourteille3, Thomas Bouillet1, Séverine Bégard1, Clément Danis1, Anne Loyens1, Nicolas Toni3, Nicole Déglon4, Vincent Deramecourt1, Susanna Schraen-Maschke1, Luc Buée5, Morvane Colin6.   

Abstract

Tauopathies are neurodegenerative diseases characterized by tau inclusions in brain cells. Seed-competent tau species have been suggested to spread from cell to cell in a stereotypical manner, indicating that this may involve a prion-like mechanism. Although the intercellular mechanisms of transfer are unclear, extracellular vesicles (EVs) could be potential shuttles. We assessed this in humans by preparing vesicles from fluids (brain-derived enriched EVs [BD-EVs]). These latter were isolated from different brain regions in various tauopathies, and their seeding potential was assessed in vitro and in vivo. We observed considerable heterogeneity among tauopathies and brain regions. The most striking evidence was coming mainly from Alzheimer's disease where the BD-EVs clearly contain pathological species that can induce tau lesions in vivo. The results support the hypothesis that BD-EVs participate in the prion-like propagation of tau pathology among tauopathies, and there may be implications for diagnostic and therapeutic strategies.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; biological fluids; exosomes; microvesicles; prion-like propagation; seeding; tauopathies

Mesh:

Substances:

Year:  2021        PMID: 34563677      PMCID: PMC8821971          DOI: 10.1016/j.ymthe.2021.09.020

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  85 in total

1.  Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.

Authors:  Longfei Jia; Qiongqiong Qiu; Heng Zhang; Lan Chu; Yifeng Du; Jiewen Zhang; Chunkui Zhou; Furu Liang; Shengliang Shi; Shan Wang; Wei Qin; Qi Wang; Fangyu Li; Qigeng Wang; Yan Li; Luxi Shen; Yiping Wei; Jianping Jia
Journal:  Alzheimers Dement       Date:  2019-08       Impact factor: 21.566

Review 2.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

3.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

Authors:  Sarah K Kaufman; David W Sanders; Talitha L Thomas; Allison J Ruchinskas; Jaime Vaquer-Alicea; Apurwa M Sharma; Timothy M Miller; Marc I Diamond
Journal:  Neuron       Date:  2016-10-27       Impact factor: 17.173

4.  The Perseus computational platform for comprehensive analysis of (prote)omics data.

Authors:  Stefka Tyanova; Tikira Temu; Pavel Sinitcyn; Arthur Carlson; Marco Y Hein; Tamar Geiger; Matthias Mann; Jürgen Cox
Journal:  Nat Methods       Date:  2016-06-27       Impact factor: 28.547

5.  Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease.

Authors:  Sudad Saman; WonHee Kim; Mario Raya; Yvonne Visnick; Suhad Miro; Sarmad Saman; Bruce Jackson; Ann C McKee; Victor E Alvarez; Norman C Y Lee; Garth F Hall
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

6.  Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.

Authors:  Charisse N Winston; Brent Aulston; Edward M Rockenstein; Anthony Adame; Olga Prikhodko; Kishan N Dave; Priyanka Mishra; Robert A Rissman; Shauna H Yuan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.

Authors:  Vincent Deramecourt; Florence Lebert; Claude-Alain Maurage; Francisco-Jose Fernandez-Gomez; Simon Dujardin; Morvane Colin; Nicolas Sergeant; Valérie Buée-Scherrer; Fabienne Clot; Isabelle Le Ber; Alexis Brice; Florence Pasquier; Luc Buée
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation.

Authors:  Sadasivam Jeganathan; Antje Hascher; Subashchandrabose Chinnathambi; Jacek Biernat; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2008-08-25       Impact factor: 5.157

9.  Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38delta or JNK2 in the presence of heparin generates the AT100 epitope.

Authors:  Hirotaka Yoshida; Michel Goedert
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

10.  Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol.

Authors:  Juan Carlos Polanco; Gabriel Rhys Hand; Adam Briner; Chuanzhou Li; Jürgen Götz
Journal:  Acta Neuropathol       Date:  2021-01-08       Impact factor: 17.088

View more
  1 in total

1.  Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment.

Authors:  Clément Danis; Elian Dupré; Orgeta Zejneli; Raphaëlle Caillierez; Alexis Arrial; Séverine Bégard; Justine Mortelecque; Sabiha Eddarkaoui; Anne Loyens; François-Xavier Cantrelle; Xavier Hanoulle; Jean-Christophe Rain; Morvane Colin; Luc Buée; Isabelle Landrieu
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 12.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.